Vitrous Analysis in Proliferative Diabetic Retinopathy

Analysis of vitreous proteins in patients undergoing pars plana vitrectomy for proliferative diabetic retinopathy

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Proliferative Diabetic Retinopathy

Age range

12 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

St. Erik Eye Hospital

Stockholm, NonUS, 11282, Sweden

About this study

To analyse and compare vitreous proteins in patients undergoing pars plana vitrectomy for proliferative diabetic retinopathy.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

proliferative diabetic retinopathy with vitreous hemorrhage

Exclusion criteria

vitreous hemorrhage of other cause than proliferative diabetic retinopathy
previous vitrectomy

Sponsors and collaborators

Lead sponsor

Anders Kvanta

Other

Registry information

Official study title

Analysis of Vitreous Proteins in Patients Undergoing Pars Plana Vitrectomy for Proliferative Diabetic Retinopathy

Important dates

Study start: 2011
Primary completion: 2014
Study completion: 2014
First posted: Nov 23, 2011
Registry last updated: Sep 25, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed